March 10, 2021
COVID-19 vaccine developed by UB startup enters human trials
By JUSTIN WEISS March 3, 2021 | 10:18pm EST A COVID-19 vaccine candidate developed by a UB spinoff company has progressed to human trials in South
January 16, 2021
EuCorVac-19 gains regulatory approval for Phase I / II clinical studies
SNAP-based EuBiologics EuCorVac-19 gains regulatory approval for Phase I/II trials in Korea EuBiologics (KOSDAQ: 206650) got an IND approval for Phase I/II clinical trial of a
Have any questions?
+61 383 766 284